Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Diabetes Care

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.29.02.06.DC05-1070PMID 16443877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.

  2004cited by this paper
• Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.

  2003cited by this paper
• Insulin Sensitizers for Polycystic Ovary Syndrome

  2003cited by this paper
• Insulin-lowering agents in the management of polycystic ovary syndrome.

  2003cited by this paper
• Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.

  2002cited by this paper
• Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome

  2002cited by this paper
• A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

  1999cited by this paper
• Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.

  1999cited by this paper
• Insulin mediators in man: effects of glucose ingestion and insulin resistance

  1997cited by this paper
• Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications

  1997cited by this paper
• Urinary myo-Inositol-to-chiro-Inositol Ratios and Insulin Resistance

  1996cited by this paper
• Urinary chiro-Inositol Excretion is an Index Marker of Insulin Sensitivity in Japanese Type II Diabetes

  1994cited by this paper
• Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men.

  1994cited by this paper
• Insulin mediators and the mechanism of insulin action.

  1993cited by this paper
• D-chiro-inositol metabolism in diabetes mellitus.

  1993cited by this paper
• chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.

  1993cited by this paper
• A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

  1991cited by this paper
• Second Messengers of Insulin Action

  1990cited by this paper
• Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

  1990cited by this paper
• Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

  1989cited by this paper
• Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.

  1989cited by this paper
• Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach

  1989cited by this paper
• Modified protocols improve insulin sensitivity estimation using the minimal model.

  1987cited by this paper
• MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

  1986cited by this paper
• Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

  1982cited by this paper
• Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

  1981cited by this paper

• Nutritional support of oocyteogenesis, ovulatory menstrual cycles with folate cycle vitamins (vitamins B1, B6, B12, active form B9) and vitamin B8 vitamers (Myo- and D-chiroinositol in a ratio of 40:1) during pre-conception preparation

  2025cites this paper
• Treatment Options for Managing Anovulation in Women with PCOS: An Extensive Literature Review of Evidence-Based Recommendations for Future Directions

  2025cites this paper
• ROLE OF METFORMIN VERSUS MYO-INOSITOL IN WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)

  2025cites this paper
• D‐Chiro Inositol Supplementation and the Occurrence of Gestational Diabetes: A Randomized Controlled Trial in China

  2024cites this paper
• The Effectiveness of Myo-Inositol in Women With Polycystic Ovary Syndrome: A Prospective Clinical Study

  2024cites this paper
• Impact of Myo-Inositol-Chiro Inositol Combination on the improvement of Polycystic Ovary Syndrome Condition

  2024cites this paper
• Changes in the Carbohydrate Profile in Common Buckwheat (Fagopyrum esculentum Moench) Seedlings Induced by Cold Stress and Dehydration

  2023cites this paper
• Observational study of usage of a combination of inositols with alpha-lactalbumin (Ovamystic) in the treatment of menstrual irregularity in PCOS

  2023cites this paper
• D-Pinitol Ameliorated Osteoporosis via Elevating D-chiro-Inositol Level in Ovariectomized Mice.

  2023cites this paper
• Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance

  2023cites this paper
• Inositols administration: further insights on their biological role

  2022cites this paper
• Diet and exercise in the management of PCOS: Starting from the basics

  2022cites this paper
• Inositols and other supplements in the management of PCOS

  2022cites this paper
• D-Chiro-inositol and PCOS: between myth and reality. The never-ending story

  2022cites this paper
• The Effect of Interleukin-6 and Tumor Necrosis Factor-Alpha Gene Polymorphism and Hormone Replacement Therapy on Polycystic Ovary Syndrome.

  2022cites this paper
• Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes

  2022cites this paper
• Inositols in the ovaries: activities and potential therapeutic applications

  2022cites this paper
• Effects of Inositol in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  2022cites this paper
• Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients

  2022cites this paper
• Health-related Quality of life of non-obese women with polycystic ovary syndrome treated with D-Chiro-Inositol: The case series study

  2022cites this paper
• Differential Gene Expression and Biological Analyses of Primary Hepatocytes Following D-Chiro-Inositol Supplement

  2021cites this paper
• New Insights into the Activities of D-Chiro-Inositol: A Narrative Review

  2021cites this paper
• The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial

  2021cites this paper
• Pathogenesis of PCOS: From Metabolic and Neuroendocrine Implications to the Choice of the Therapeutic Strategy

  2021cites this paper
• Polikistik Over Sendromunda Güncel Terapötik Ajanlardan İnositol ve Alfa Lipoik Asit Takviyesi Üzerine Bir Derleme

  2021cites this paper
• An innovative approach to polycystic ovary syndrome

  2021cites this paper
• A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy

  2020influential citation
• Lipid Signaling in Human Diseases

  2020cites this paper
• Inositols and metabolic disorders: From farm to bedside

  2020cites this paper
• Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS

  2020cites this paper
• [Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome].

  2020cites this paper
• Conceptualization and synthesis of first inosito-inositol (decahydroxydecalin, DHD): In silico binding to β-amyloid protein.

  2020cites this paper
• Systematic analysis of the biological roles and pharmacological properties of D-chiro-inositol

  2020cites this paper
• Placental Inositol Reduced in Gestational Diabetes as Glucose alters Inositol Transporters and IMPA1 enzyme expression.

  2020cites this paper
• Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome

  2020cites this paper
• Inositols: reflections on how to choose the appropriate one for PCOS

  2020cites this paper
• What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment

  2020cites this paper
• Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary

  2020cites this paper
• Inositols in PCOS

  2020cites this paper
• Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial

  2019cites this paper
• Inositol and antioxidant supplementation: Safety and efficacy in pregnancy

  2019cites this paper
• Inositols’ Importance in the Improvement of the Endocrine–Metabolic Profile in PCOS

  2019cites this paper
• Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both

  2019cites this paper
• The distribution of D-chiro-inositol in buckwheat and its antioxidative effect in HepG2

  2019cites this paper
• The effect of myo‐inositol/di‐chiro‐inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta‐analysis

  2019cites this paper
• The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.

  2019cites this paper
• Management ofwomenwithPCOSusing myo-inositol and folic acid . New clinical data and reviewof the literature

  2018cites this paper
• Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature

  2018cites this paper
• Inositols in Insulin Signaling and Glucose Metabolism

  2018cites this paper
• The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review

  2018cites this paper
• Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?

  2018cites this paper
• Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients

  2018cites this paper
• Regulation of Inositol Biosynthesis: Balancing Health and Pathophysiology.

  2018cites this paper
• Postpartum assessment of the beta cell function and insulin resistance for Chinese women with previous gestational diabetes mellitus

  2018cites this paper
• Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.

  2018cites this paper
• Myo‐inositol and D‐chiro‐inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model

  2018cites this paper
• Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials

  2017cites this paper
• Identification and Functional Implications of Sodium/Myo-Inositol Cotransporter 1 in Pancreatic β-Cells and Type 2 Diabetes

  2017cites this paper
• Use of Myo-inositol for Ovulation Induction in Patients with Polycystic Ovary Syndrome

  2017cites this paper
• [The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome].

  2017cites this paper
• High Value-Added Biomolecules from Beach Waste of Marine Origin-Screening for Potential Candidates among Seagrass of the Cymodoceaceae Family

  2017cites this paper
• Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols

  2017influential citation
• A mio-inozitol jótékony hatása inzulint

  2017cites this paper
• d-Chiro inositol ameliorates endothelial dysfunction via inhibition of oxidative stress and mitochondrial fission.

  2017cites this paper
• Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome

  2016cites this paper
• Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside.

  2016cites this paper
• Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol

  2016cites this paper
• Inositol as putative integrative treatment for PCOS.

  2016cites this paper
• Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols

  2016cites this paper
• The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

  2016cites this paper
• Inositol Treatment and ART Outcomes in Women with PCOS

  2016cites this paper
• Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome

  2016cites this paper
• Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials

  2016cites this paper
• How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin

  2016cites this paper
• Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives

  2016cites this paper
• Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus

  2016cites this paper
• Inositol and human reproduction. From cellular metabolism to clinical use

  2016cites this paper
• A review of prevention strategies for gestational diabetes: is there a missing X-factor?

  2016cites this paper
• Myo-Inositol and D-Chiro-Inositol in Polycystic Ovarian Syndrome. -

  2016cites this paper
• Inositol – A natural treatment for polycystic ovarian syndrome?

  2016cites this paper
• Pretreatment with myo-inositol in patients undergoing gonadotropins multiple follicular stimulation for IVF

  2016cites this paper
• Die “anderen” Inositole und ihre Phosphate: Synthese, Biologie und Medizin (sowie jüngste Fortschritte in der myo‐Inositolchemie)

  2016cites this paper
• Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction

  2016cites this paper
• Synthesis and biological activities of d-chiro-inositol analogues with insulin-like actions.

  2016cites this paper
• Reflections on inositol(s) for PCOS therapy: steps toward success

  2015cites this paper
• The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study

  2015cites this paper
• New insights into infertility associated with polycystic ovarian syndrome

  2015cites this paper
• PCOS and Insulin Resistance (IR): From Lifestyle to Insulin Sensitizers

  2015cites this paper
• Myoinositol Supplementation on Insulin Resistance in Gestational Diabetes

  2015cites this paper
• The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol

  2015cites this paper
• Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with

  2015cites this paper
• Inositol Modulation of Essential Metabolic Pathways of Insulin Resistance in Metabolic Syndrome, Polycystic Ovarian Syndrome, and Type 2 Diabetes

  2015cites this paper
• Inositol and acne.

  2015cites this paper
• Treatment Strategies for the Infertile Polycystic Ovary Syndrome Patient

  2015cites this paper
• Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS.

  2015cites this paper
• Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol

  2015cites this paper
• Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.

  2015cites this paper
• Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance

  2015cites this paper
• Myo‐inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome

  2014cites this paper
• Inositol: history of an effective therapy for Polycystic Ovary Syndrome.

  2014cites this paper